remain overweight reduc price target prior
follow sharp reset expect includ cut ep estim
retain ow rate five key reason signific near-term cost
pressur far greater previous envis primari driver
earn reset yet remain transitori includ mhk control
product curtail price under-absorb start-up cost
mhk control cost inflat downshift mix across floor
 ceram uncertain increment off-set price better
volum posit mix area europ ceram europ lvt still
yet see posit impact mhk upcom global capac open
natur go ramp period still addit organ growth
assum bp organ volum acceler balanc sheet
net leverag pro forma godfrey hirst remain strong leav option
today downward move stock trade
new ep estim surpris see stock remain
penalti box near-term becom clear fundament stabil
expect multipl expans warrant price target
reflect ep vs mhk histor rang
estim revis forecast ep prior
ebitda bn prior bn
weve reduc organ growth prior
prior cut op margin
bridg illustr ebit bridg forecast product
mn potenti conserv organ volum mn mn increment
godfrey hirst lower start-up mn slightli posit net price-cost partial
off-set higher mn neg fx higher invest
mn also assum higher tax rate vs year
lower usd
return equiti ttm
link barclay live interact chart
quarterli annual ep usd
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
margin return data
balanc sheet cash flow mn
equival
short long-term debt
flow oper
valuat leverag metric
overweight believ earn growth
acceler follow period heighten
yet transitori cost pressur moreov
contribut invest
growth sustain product improv
repres sourc upsid next year beyond
addit see sizeabl balanc sheet capac
 reinvest
even better expect product improv
stronger growth aris quick ramp
new lvt capac better growth
price-cost headwind deceler
product challeng ramp lvt capac
margin pressur lvt ceram
guidanc midpoint barclay consensu
revenu bn y/i short bn estimate y/i
consensu bn organ growth constant day fx ex acquisit
estimate
floor bn organ vs estimate
ceram mn vs estimate organ growth
floor row mn vs estimate organ growth
adj ebitda mn vs barclay mn consensu mn adj
ebitda margin short estimate
adj oper margin bp y/i estimate bp y/i
floor vs estimate
ceram vs estimate
floor row vs estimate
adj ep barclay consensu
mln reportedbarclaysconsensusnet bpsadj ebitda bpsadj barclay mohawk inc
world largest floor manufactur bn revenu
focu ceramic/til carpet rug lamin wood sheet vinyl lvt stone
floor oper three segment floor north america sale global
ceram floor rest world floor account
oper incom ceram repres floor row gener op
within sale gener residenti total sale
commerci market total new residenti construct
total account sale revenu repres
sale made western europ canada russia
ceo jeffrey lorberbaum own mhk common stock sinc begin
deploy bn acquisit compani also spent bn capital-expenditure
sinc begin previous spent bn seven year
rate overweight price target price target repres
ebitda assum net debt bn prior price target
repres prior adj ebitda estim
valuat upside/downsid scenario
 oper gener administr custom refund incom op non-recur tax-benefit goodwil intang restructur charg net dilut earningsfrom stock-bas compadjust dilut ep cont basic dilut earn per ebitda calcul net earn ex incom interest depreci ebitda margin barclay
 oper gener administr custom refund incom op non-recur tax-benefit goodwil intang restructur charg net dilut earningsfrom stock-bas compadjust dilut ep cont basic dilut earn per ebitda calcul net earn ex incom interest depreci ebitda margin barclay
matthew bouley herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
